المؤلفون: Gerard Dijkstra, Andrea E. van der Meulen-de Jong, Herma H. Fidder, M. W. M. D. Lutgens, Lennard P L Gilissen, Nofel Mahmmod, J Schultheiss, Shaden Mahmmod, Frank Hoentjen, Adriaan C I T L Tan, Lisa J T Smits, Bas Oldenburg, Ad A. van Bodegraven

المساهمون: Groningen Institute for Organ Transplantation (GIOT), Translational Immunology Groningen (TRIGR), Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI)

المصدر: Inflammatory Bowel Diseases, 27(12), 1954-1962. OXFORD UNIV PRESS INC
Inflammatory Bowel Diseases, 27, 1954-1962
Inflammatory Bowel Diseases, 27(12), 1954-1962. LIPPINCOTT WILLIAMS & WILKINS
Inflammatory Bowel Diseases, 27, 12, pp. 1954-1962

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Inflammatory bowel disease, anti-TNF-alpha, 03 medical and health sciences, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, Gastrointestinal Agents, inflammatory bowel disease, Internal medicine, Immunology and Allergy, Medicine, Humans, In patient, biosimilars, biologic therapy, Adverse effect, Biosimilar Pharmaceuticals, Retrospective Studies, ulcerative colitis, Adult patients, business.industry, Drug Substitution, Gastroenterology, Inflammatory Bowel Diseases, Antibodies, Monoclonal, Crohn disease, medicine.disease, Ulcerative colitis, Infliximab, Treatment Outcome, 030220 oncology & carcinogenesis, Chronic Disease, 030211 gastroenterology & hepatology, Female, business, infliximab, Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5], Cohort study, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65b46bb5e73e3a6fedc98560df43246e
http://hdl.handle.net/1887/3276514